Artificial pancreas devices so far cannot compensate the daily varying food intake or physical activities of diabetes patients. The University of Bern, the Bern University Hospital and an industry partner have therefore set out to develop a more flexible device to continuously control patients’ blood sugar.

A safety concept for removing brain tumours developed at the Inselspital leads to the best results for patients anywhere in the world, in honour of which it was awarded a prize at this year’s European Congress of Neurosurgery in Madrid.

The FASTER software developed in Bern can detect within minutes the areas of the brain that will be left with long-term damage following a stroke. The previous version – BraTumIA for tumour segmentation – has been in use around the world since 2014.

Good communication in the operating room prevents patient complications. This is proved by a Swiss study, recently published in British Journal of Surgery.

Faster than the doctor, but equally meticulous and free of charge: the Bern computer program BRaTumIA for the recognition of malignant brain tumours is proving to be an international hit.

Dark chocolate consumption protects from cardiovascular diseases but underlying mechanisms are not fully understood. Research from the Universities of Bern and Zürich and the University Hospital Bern (Inselspital) suggests that a single intake of half a bar of dark chocolate with high cocoa content…

During a viral infection, immune cells control the blood stem cells in the bone marrow and therefore also the body's own defences. These recent findings by Bernese researchers could allow for new forms of therapy, such as for bone marrow diseases.

When tumour cells no longer degrade themselves, cancer may develop. Using black skin cancer as an example, Bern Researchers have now shown that a protein plays an important role in the process of degradation of tumour cells. By reactivating this degradation therapeutically, you can virtually force tumours to…

Last generation drug-eluting stents are the safest and most effective therapy for percutaneous coronary revascularization in female heart patients. This was demonstrated today in a large-scale analysis by the Department of Cardiology at Inselspital.